Twenty-eight hypertriglyceridemic type 2 diabetic patients were assigned to three different hypolipidemic treatment groups. Twelve were treated with benfluorex 150 mg TID, nine with fenofibrate 100 mg TID, and seven with bezafibrate 200 mg TID. After one month, serum triglyceride (TG) fell by 33%, serum cholesterol (Chol) by 17%, very low-density lipoprotein (VLDL)-TG by 36%, and low-density lipoprotein (LDL)-Chol by 20% in benfluorex-treated patients. High-density lipoprotein (HDL)-Chol did not change significantly. A significant decrease in glycosylated hemoglobin also occurred. In fenofibrate-treated patients serum TG decreased by 50% and VLDL-TG by 60%. LDL-Chol increased by 22% and HDL-Chol by 16%. Similar results were obtained in the bezafibrate group, eg, a significant decrease in serum TG (44%) and VLDL-TG (54%) and an increase in LDL-Chol (16%) and in HDL-Chol (21%) serum levels. Although the rise in LDL-Chol after administration of the two fibrates was associated with an increase in HDL-Chol, LDL-Chol to HDL-Chol ratio did not change in the fenofibrate and bezafibrate groups, but significantly decreased in benfluorex-treated patients. This may be of major importance in the development of atherosclerotic vascular lesions in diabetic patients.
|Number of pages||12|
|Journal||Current Therapeutic Research|
|Publication status||Published - 1986|
ASJC Scopus subject areas